1. Home
  2. EQH vs NBIX Comparison

EQH vs NBIX Comparison

Compare EQH & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Equitable Holdings Inc.

EQH

Equitable Holdings Inc.

HOLD

Current Price

$43.80

Market Cap

12.6B

Sector

Finance

ML Signal

HOLD

Logo Neurocrine Biosciences Inc.

NBIX

Neurocrine Biosciences Inc.

HOLD

Current Price

$166.60

Market Cap

13.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EQH
NBIX
Founded
1859
1992
Country
United States
United States
Employees
8000
N/A
Industry
Specialty Insurers
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.6B
13.2B
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
EQH
NBIX
Price
$43.80
$166.60
Analyst Decision
Buy
Strong Buy
Analyst Count
11
22
Target Price
$56.82
$180.91
AVG Volume (30 Days)
4.0M
1.1M
Earning Date
05-04-2026
05-05-2026
Dividend Yield
2.60%
N/A
EPS Growth
N/A
41.95
EPS
N/A
1.91
Revenue
N/A
$161,626,000.00
Revenue This Year
$43.13
$24.73
Revenue Next Year
$7.45
$13.14
P/E Ratio
N/A
$85.87
Revenue Growth
N/A
977.51
52 Week Low
$35.20
$122.14
52 Week High
$56.61
$169.57

Technical Indicators

Market Signals
Indicator
EQH
NBIX
Relative Strength Index (RSI) 53.51 62.32
Support Level $42.30 $153.96
Resistance Level $46.93 $169.57
Average True Range (ATR) 1.15 4.79
MACD -0.01 -0.19
Stochastic Oscillator 51.02 80.36

Price Performance

Historical Comparison
EQH
NBIX

About EQH Equitable Holdings Inc.

Equitable Holdings Inc is a financial services company providing retirement, asset management, and wealth management solutions for individual and institutional clients, operating through three segments. The Retirement segment generates the majority of revenue and offers annuities, retirement savings plans, institutional savings products, and includes the spread lending business. The Asset Management segment provides diversified investment management and related services globally through Institutional, Retail, and Private Wealth channels and reflects the business of AB. The Wealth Management segment offers advisory accounts, financial planning and advice, life insurance, and annuity products. Revenues are earned predominantly from fee income, income from investments, and insurance premiums.

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.

Share on Social Networks: